Effects of monotherapy with intra-nasal corticosteroid or combined oral histamine and leukotriene receptor antagonists in seasonal allergic rhinitis

Keyphrases

• Mometasone Furoate 100%
• Monotherapy 100%
• Seasonal Allergic Rhinitis 100%
• Intranasal Corticosteroids 100%
• Leukotriene Receptor Antagonist 100%
• Histamine Receptor Antagonist 100%
• Placebo 80%
• Acoustic Rhinometry 60%
• Rhinomanometry 60%
• No Significant Difference 40%
• Montelukast 40%
• Once-daily 40%
• Nasal Nitric Oxide 40%
• Intranasal 40%
• Cetirizine 40%
• Nasal Flow 40%
• Peak Flow 20%
• Beneficial Effects 20%
• Treatment Duration 20%
• Active Treatment 20%
• Placebo-controlled 20%
• Nitric Oxide 20%
• Subjective Measures 20%
• Treatment Response 20%
• Nasal Symptoms 20%
• Laboratory Measurements 20%
• Co-therapy 20%
• Nasal Blockage 20%
• Antihistamines 20%

Medicine and Dentistry

• Placebo 100%
• Mometasone Furoate 100%
• Monotherapy 100%
• Pollen Allergy 100%
• Leukotriene Receptor Blocking Agent 100%
• Histamine Antagonist 100%
• Nitric Oxide 60%
• Acoustic Rhinometry 60%
• Rhinomanometry 60%
• Montelukast 40%
• Cetirizine 40%
• Treatment Response 20%
• Mediator 20%
• Peak Expiratory Flow 20%